Research and Development

Showing 15 posts of 9607 posts found.

Lilly offers insulin at 40% discount

December 13, 2016 Research and Development, Sales and Marketing Blink Health, Eli Lilly

Eli Lilly has announced that it will offer its insulin medication, including Humalog, at a 40% discount for eligible patients …
ceo_david_hallal_image_sqaure_image

Alexion loses CEO & CFO as internal investigation continues

December 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion

Alexion Pharmaceuticals has revealed that its CEO David Hallal (pictured) and CFO Vikas Sinha have resigned effective immediately in connection …
basel_site

Phase 3 eye drug combo failure for Novartis

December 12, 2016 Research and Development, Sales and Marketing Novartis, ophthotech

Novartis’ has failed in its attempt to expand the applications of its anti-VEGF eye treatment Lucentis (ranibizumab) after the drug …
shutterstock_38078521

AZ and Lilly come together to battle Alzheimer’s

December 9, 2016 Research and Development, Sales and Marketing AZ, lilly

Pharma titans Eli Lilly and AstraZeneca have announced they are to join forces to co-develop a potential Alzheimer’s treatment, currently …
mice

Flickering LEDs could light the way for new Alzheimer’s treatment

December 8, 2016 Medical Communications, Research and Development Alzheimer's, Cognito therapeutics, mice

Research to find a potential new treatment for Alzheimer’s was hit a blow late last month, as Eli Lilly discontinued …
sicorbio

Teva embroiled in internal bribery investigation

December 8, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, bribery

Israeli pharmaceutical firm Teva has confirmed it is embroiled in an ongoing internal investigation into allegations of bribery, after the …

Mylan to restructure and slash around 10% of workforce

December 8, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, epipen, job losses

Mylan has submitted a regulatory filing to the Securities and Exchange Commission to announce that it would be potentially cutting …

BMS shares promising Opdivo/Yervoy data for advanced bladder cancer

December 8, 2016 Research and Development BMS, Yervoy, opdivo

BMS has revealed new efficacy data on the combination of its immunotherapies Opdivo (nivolumab) and Yervoy (ipilimumab) for the treatment …
shutterstock_212432119

New Alzheimer’s research edges closer to treatment & prevention

December 7, 2016 Research and Development Alzheimer's

A new study has shed light on the possible prevention and treatment of Alzheimer’s disease thanks to findings centred on …
lisa_anson

AstraZeneca’s Lisa Anson appointed president of ABPI

December 7, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Lisa Anson, current president of AstraZeneca UK & Ireland, has been appointed to the position of president of ABPI. Lisa …
imbruv_pack

Janssen reveals positive results from longest follow-up of Imbruvica

December 7, 2016 Research and Development AbbVie, Cilag, Janssen, Pharmacyclics, imbruvica

Janssen used the 5th Annual American Society of Hematoly Meeting and Exposition to reveal that a five-year study of Imbruvica …
jakob-riis

Novo pledges single-digit cap on drug price hikes

December 7, 2016 Medical Communications, Research and Development, Sales and Marketing Jakob Riis, Novo Nordisk

Novo Nordisk US chief Jakob Riis (pictured) has announced the insulin giant’s commitment to limit its price increases to single-digit …

Pfizer slapped with record £84.2 million fine for 2,600% price increase

December 7, 2016 Medical Communications, Research and Development CMA, Flynn Pharma, Pfizer, fine

Pfizer has been hit with a record fine by The Competition and Markets Authority for the increase in the price …
The Gateway to Local Adoption Series

Latest content